“Stakeholder perspective –Pharmacists”...Source: Auffray C, Balling R, Barroso I, et al....
12
Prof. John Yfantopoulos “Stakeholder perspective – Pharmacists” Tuesday 15 th December 2020 Prof. John Yfantopoulos University of Athens Greece
Transcript of “Stakeholder perspective –Pharmacists”...Source: Auffray C, Balling R, Barroso I, et al....
-
Prof. John Yfantopoulos
“Stakeholder perspective –Pharmacists”
Tuesday 15th December 2020
Prof. John Yfantopoulos University of Athens Greece
-
BIG-DATA: Structure
•Brief Remarks on European Commission
•Priorities
•Opportunities
•Areas of Collaboration
Professor John Yfantopoulos University of Athens
-
European Commission’s Term of Big data
•Big Data in health encompasses •high volume, •high diversity biological, • clinical, environmental, and • lifestyle information collected from • single individuals (Personalized Medicine) to large
cohorts, in relation to their health and wellness status, at one or several time points.
Source: Auffray C, Balling R, Barroso I, et al. Making sense of big data in health research: towards an EU action plan. Genome Med 2016;8:71
Professor John Yfantopoulos University of Athens
-
European Commission: Big Data in Public Health
• increasing earlier diagnosis and the effectiveness and quality of treatments
• widening possibilities for prevention of diseases by identification of risk factors for disease
• improvement of pharmacovigilance and patient safety
• ability to make more informed decisions
• prediction of health outcomes & Health Related Quality of Life (HRQoL)
Exponential Increase inBig data Publications
Source: (2019) Roberta Pastorino et al European Journal of Public Health, Vol. 29, Supplement 3, 23–27
-
Priorities
Professor John Yfantopoulos University of Athens
-
Raw Data is Collected
Data is Processed
Clean Data
Exploratory Data
Analysis
MachineLearning
AlgorithmsStatisticalModels
CommunicateVisualizations
ReportFindings
Rational Decisions
Build Data Product
Real World
From Big Data to Rational Decisions
Professor John Yfantopoulos University of Athens
-
Select Variables
Query Data
Data Cleaning
Outlier Detection
Normalize Data
Testing Data
Automate Process
Professor John Yfantopoulos University of Athens
-
Areas of Collaboration
Professor John Yfantopoulos University of Athens
-
Big data uses
within Health
System
Pharmacy
Optimization
of clinical
decision
Formulary
management
and adverse
event
monitoring
Quality of care
and patient
outcomes
Better care
transitions via
data related to
medication
adherence
Enhanced
application of
evidence-based
medicine
Claims
Cost and
Utilization
data
Big Data in a Pharmacy System
Use of Big data to Promote Health SystemPharmacy Operations &Management
Source: Ma C, Smith HW, Chu C, Juarez D. Big data in pharmacy practice:
Current use, challenges, and the future. Integrated Pharm Res Pract. 2015;4:91–99Professor John Yfantopoulos University of Athens
-
Big Data Sources
y = 0,0013x1,2158
R² = 0,7378
0
200
400
600
800
1000
1200
1400
0.00 10,000.0020,000.0030,000.0040,000.0050,000.0060,000.0070,000.0080,000.0090,000.00
Cost & Pharma Data
Professor John Yfantopoulos University of Athens
-
Comparative Policies on Pharmaceutical Systems
E- Prescription
E-Regulation
Pricing & Procurement
Professor John Yfantopoulos University of Athens
-
Fragmented
Data
Privacy Preserving
Data Management
Medication Errors
Adverse Events ManagementDrug Supply Cost
Personalized Treatment
Management
Harmonization in Prioritization & Data
Value Solutions
Key Messages:Move Towards Data Driven Decisions
Thanks for your Attention Email : [email protected]
Professor John Yfantopoulos University of Athens
“We are moving slowly
into an era where big
data is the starting
point, not the end.”
